welcomes you to the new, improved website!In this manuscript, the authors describe their experience with the treatment of 8 high risk patients with pure, severe aortic valve regurgitation, using the self-expandable Acurate TA prosthesis through a transapical approach. All procedures were carried out successfully with no 30-day mortality or stroke. None of the patients had more that grade I residual aortic regurgitation and none of them required permanent pacemaker implantation.
You are here:
Expanding the Limits: Transapical Transcatheter Aortic Valve for Severe Aortic Regurgitation
Source: JACC Cardiovascular Interventions
Keywords:
Author(s): Wendt D, Kahlert P, Pasa S, El-Chilali K, Al-Rashid F, Tsagakis K, Dohle DS, Erbel R, Jakob H, Thielmann M.
2 Comments
This study shows the expanding use of catheter approach to repair cardiac valves in patients who are not candidates for standard approaches,
My questions are: 1.How long were these patients hospitalized post valve replacement ? 2.What complications are unique this approach? 3.Is this procedure useful in heavily calcified annulus?
Congratulation for the success you achieved in the eight patients.
Dear Reader, many thanks for your interest and quetions. According to the Hospital stay please refer to Table 2, which gives a detailed overview of the ICU and Hospital stay. According to your 2nd question: Complications might be potential acute intraoperative valve dislocation. 3.: Yes, this valve has been initially designed to treat AS, therefore, it is as well possible to implant in heavily calcified aortic annuli.